Title: Signaling Systems Using Cyclic Nucleotides as Mediators: Focus on the Regulation of Gene Transcripti
1Signaling Systems Using Cyclic Nucleotides as
Mediators Focus on the Regulation of Gene
Transcription by Glucagon
2Cyclic Nucleotides the Nobel Prize
- Hormonal action through cAMP- Sutherland (1971)
- Reversible protein phosphorylation- Fisher and
Krebs (1992) - G proteins cyclic nucleotide synthesis- Gilman
and Rodbell (1994) - Nitric oxide cGMP- Furchgott, Ignarro, and
Murad (1998) - Cyclic nucleotides the nervous system-
Carlsson, Greengard, and Kandel (2000) - Nobel e-museum http//www.Nobel.Se/index.Com
Beavo, J. and L. Brunton Nat Rev Mol Cell Biol
2002 Sep3(9)710-8
3cAMP/ cGMP mediate diverse physiological
processes
- Musculature
- Striated contraction
- Smooth muscle relaxation
- Cardiac contractility
- Energy/ electrolyte homeostasis
- Gluconeogenesis
- Glycolysis
- Lipogenesis
- Glomerular filtration
- Reproduction
- Testicular/ ovarian function
- Sperm mobility/ chemotaxis
- Acrosome reaction
- Nervous system
- Neurotransmission
- Learning and memory
- Phototransduction
- Olfaction
- Circadian rhythm
- Plasticity
- Cellular processes
- Proliferation
- Differentiation
- Ion transport
- Apoptosis
4Structures of Cyclic AMP/GMP
Beavo, J. and L. Brunton Nat Rev Mol Cell Biol
2002 Sep3(9)710-8
5Cyclic nucleotide synthesis/ degradation
- Cyclases convert ATP/GTP to cAMP/cGMP
- Adenylyl cyclases ATP? cAMP PPi
- 9 classes (transmembrane)
- Guanylyl cyclases GTP ? cGMP PPi
- Receptors for extracellular ligands
- Classified by number of transmembrane segments
(zero, one, or multiple) - Phosphodiesterases
- cleave phosphodiester bond (5 AMP, 5 GMP)
6Nucleotide interaction in cyclase active sites
- Lysine (K938) and Aspartate (D1018) in AC
hydrogen bond to N-1 and N-6 of ATP - Cysteine (C541) and Glutamate (E473) in GC
contact O-6 and N-2 of GTP - These residues are highly conserved and invariant
in ACs and CGs
Wedel and Garbers. 2001 Annu. Rev. Physiol.
63215-233
7Receptor/ ligand activation of cyclases
- cAMP
- 7TM receptors
- G-coupled protein receptors activate/ inhibit AC
by G?-GTP subunit interaction - cGMP
- Nitric oxide binds soluble GC, activation
- Atrial and B-type natriuretic peptides bind
natriuretic peptide receptors (NPR), activation - NPRs have intrinsic GC activity (C-terminus)
- Enterotoxins bind GC in intestinal tract
8Effectors of cAMP/ cGMP action
- Protein kinases
- cAMP-dependent (PKA)
- cGMP-dependent (PKG)
- Multiple substrates
- Cyclic nucleotide binding proteins
- Cyclic nucleotide-gated channels
- Guanine-nucleotide exchange factors (GEFs)
- Phosphodiesterases (PDEs)
- cGMP () PDE2
- Modulate cyclic nucleotide concentrations
- Transcriptional regulation
- cAMP-response element binding protein (CREB)
- cAMP-response element (CRE) in DNA promoters
9Cellular Targets of cAMP/ cGMP
cAMP cGMP
Beavo, J. and L. Brunton Nat Rev Mol Cell Biol
2002 Sep3(9)710-8
10GCPRs and cAMP
- Touhara, K. Microsc Res Tech 2002 Aug
158(3)135-41
Beavo, J. and L. Brunton Nat Rev Mol Cell Biol
2002 Sep3(9)710-8
Zaccolo et al. Curr Opin Cell Biol. 2002
Apr14(2)160-6. Review
11Enterotoxin activates cGMP/ cross-talk with cAMP
Lucas, K et al. 2000 Pharmacol Rev. 52375-413
12cAMP Dependent Protein Kinase (PKA)
- Regulation of cytosolic phosphoenolpyruvate
carboxykinase-1 (PEPCK-C) gene expression by
glucagon
13Glucagon
- Produced by pancreatic islets in response to
hypoglycemia - Counteracts insulin
- Promotes hepatic mobilization of glucose
- Regulates rate of glycolysis and gluconeogenesis
by - Phosphorylation of key enzymes
- Transcriptional regulation of key metabolic
enzymes - PEPCK-C regulation
Jiang and Zhang. Am J Physiol Endocrinol Metab
284E671-678, 2003
Activated cAMP dependent protein kinase A is
the primary mediator in both processes
14Jiang and Zhang. Am J Physiol Endocrinol Metab
284E671-678, 2003
15PKA
- Ser/ Thr Kinase
- Holoenzyme
- Tetramer
- 2 Regulatory subunits
- RI?,RI?,RII?,RII?
- Blocks the active site (C subunit)
- 2 Catalytic subunits
- C?, C?, C?
- Regulation by cAMP
- Binding of cAMP to R subunit reduces affinity of
proteinprotein interaction
16RI? binds 2 molecules cAMP
cAMP
Su, Y. et al. Science 1995 Aug 11269(5225)807-13
17Catalytic subunit
ATP
Taylor, S. et al. Pharmacol Ther 1999
May-Jun82(2-3)133-41
18PKA subcellular location
- Phosphorylation of diverse substrates by PKA is
dependent on subcellular location - Type I holoenzyme (RI? and RI? dimer)-
cytoplasmic - Type II (RII? and RII? dimer)- associated with
cellular structures and organelles - Localization of Type II PKA is mediated by
nonenymatic scaffold proteins, A-kinase anchoring
proteins (AKAPs) - Compartmentalization of PKA ensures coordinate
regulation by cAMP gradients as generated by AC
Reviewed by Alto, E. et al. Diabetes 2002 Dec 51
Suppl 3S385-8
19AKAPs dictate cellular location of PKA in the
heart
Kapiloff, Michael S. Mol Pharmacol 2002 62
193-199
20Dissociation of PKA holoenzyme
- cAMP activation of PKA can be visualized in vitro
using fluorescent resonance energy transfer (FRET)
Zaccolo, M. et al. Nat Cell Biol. 2000
Jan2(1)25-9
21Zaccolo, M. et al. Nat Cell Biol. 2000
Jan2(1)25-9
22Zaccolo, M. et al. Nat Cell Biol. 2000
Jan2(1)25-9
23PKA and transcriptional regulation
- PKA regulates gene transcription in response to
cAMP - Glucagon induction of PCK1 (rate limiting enzyme
in gluconeogenesis) - Requires C? translocation in to nucleus
- Diffusion (passive) through nuclear pore complex
- C has no endogenous NLS
- Phosphorylates transcription factors
- Nuclear export of C? is facilitated by inhibitor,
PKI - Not absolutely required to stop transcription
24C?- PKA nuclear translocation is stimulated by
cAMP
(-) dibutyryl cAMP (1 mM)
() dibutyryl cAMP (1 mM)
(-) dibutyryl cAMP (1 mM)
() dibutyryl cAMP (1 mM)
Anti C-PKA immunofluorescence was detected with
anti-rabbit IgG antibody conjugated with
fluorescein (A and B) or rhodamine (C and D).
Ventra, C. et al. J Neurochem 1996
Apr66(4)1752-61
25Evidence that RII can also translocate
Wiley, J. et al. J Biol Chem 1999 Mar
5274(10)6381-7
26CREB
- cAMP responsive element (CRE) binding protein
- Leucine zipper, basic DNA binding domain (bZIP)
- CBP interaction domain
- Kinase-inducible domain
- Ser133 phosphorylated by PKA
- Promotes interactions with CBP
Reviewed by Daniel, P. et al. Annu Rev Nutr
199818353-83
27rCREB dimer phosphorylation induces
conformational change
S133 S133-P S133-P
Usukura, J. et al. Genes Cells 2000
Jun5(6)515-22
28PEPCK promoter
- Highly regulated
- CREB binding elements as well as
- Thyroid hormone, glucocorticoid, isulin, and
peroxisome proliferator-activated receptor
responsive elements - Glucagon synergistically regulates PEPCK with
glucocorticoids through the co-activator PGC-1
Reviewed by Hanson, R. Reshef, L. Annu. Rev.
Biochem. 66, 581-611 (1997)
29Dominant negative CREB causes hypoglycemia
- A-CREB (dominant neg)
- Acidic extension of leucine zipper
- Disrupts DNA binding of CREB members but enhances
affinity - Expression confined to liver
- A-CREB transgenic mice exhibit profound
hypoglycemia at birth - Altered expression of CREB regulated enzymes
Herzig, S. et al. Nature 2001 Sep
3413(6852)179-83
30CREB PCG-1 synergism
Herzig, S. et al. Nature 2001 Sep
3413(6852)179-83
31Conclusions
- Cyclic nucleotides regulate a diverse array of
physiological responses to hormones and growth
factors - Responses to increased cAMP are mediated by
effectors such as PKA, which may also be highly
regulated - Gene transcription in response to cAMP requires
PKA translocation, phosphorylation of
transcription factors (CREB), and coordination
with other co-activators and enhancers